GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab
Condition(s):Previously Treated Metastatic Adenocarcinoma of the PancreasLast Updated:April 6, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Previously Treated Metastatic Adenocarcinoma of the PancreasLast Updated:April 6, 2021Completed
Condition(s):Melanoma Stage Iv; Renal Cell Carcinoma, MetastaticLast Updated:December 5, 2022Recruiting
Condition(s):Colorectal Cancer MetastaticLast Updated:October 23, 2023Recruiting
Condition(s):Metastatic Renal Cell Carcinoma; Clear-cell Metastatic Renal Cell CarcinomaLast Updated:March 12, 2024Recruiting
Condition(s):Renal Cancer MetastaticLast Updated:February 28, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:November 13, 2019Completed
Condition(s):Non Small Cell Lung CancerLast Updated:January 18, 2024Completed
Condition(s):Lung Cancer, Nonsmall Cell; Lung Cancer Stage IIILast Updated:November 7, 2023Recruiting
Condition(s):Non Small Cell Lung Cancer Stage IIIBLast Updated:October 28, 2020Terminated
Condition(s):LymphomaLast Updated:March 29, 2022Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.